Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit

scientific article published on 27 August 2019

Structure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.XPHS.2019.08.018
P698PubMed publication ID31469998

P50authorTapan K. DasQ51739364
P2093author name stringLi Tao
Zhi Chen
Ming Zeng
Xiang Cao
Kaimeng Zhou
Richard Ludwig
James Bautista
Neil Hershey
P2860cites workCharacterization of succinimide stability during trypsin digestion for LC-MS analysis.Q51105543
High throughput peptide mapping method for analysis of site specific monoclonal antibody oxidation.Q51631949
Isomerization and Oxidation in the Complementarity-Determining Regions of a Monoclonal Antibody: A Study of the Modification-Structure-Function Correlations by Hydrogen-Deuterium Exchange Mass Spectrometry.Q51739313
Subunit Mass Analysis for Monitoring Multiple Attributes of Monoclonal AntibodiesQ57031668
Validation of a peptide mapping method for a therapeutic monoclonal antibody: what could we possibly learn about a method we have run 100 times?Q73524714
Fast analysis of recombinant monoclonal antibodies using IdeS proteolytic digestion and electrospray mass spectrometryQ84148649
Isomerization in the CDR2 of a monoclonal antibody: Binding analysis and factors that influence the isomerization rateQ84639225
Characterization and quantification of succinimide using peptide mapping under low-pH conditions and hydrophobic interaction chromatographyQ90024811
Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC: overview and applicationsQ26824543
The future of immune checkpoint therapyQ28259862
Structure-based prediction of asparagine and aspartate degradation sites in antibody variable regionsQ28539968
Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteinsQ28618536
Molecular clocksQ30327762
Formulation considerations for proteins susceptible to asparagine deamidation and aspartate isomerization.Q30356718
Separation and characterization of an IgG2 antibody containing a cyclic imide in CDR1 of light chain by hydrophobic interaction chromatography and mass spectrometryQ33324712
Mass spectrometry for structural characterization of therapeutic antibodiesQ33362439
Post-translational protein modifications in antigen recognition and autoimmunityQ34319948
Protein therapeutics: a summary and pharmacological classificationQ34728463
Post-translational modifications in the context of therapeutic proteinsQ36620451
Heterogeneity of monoclonal antibodiesQ36935493
Post-translational modifications of recombinant proteins: significance for biopharmaceuticalsQ37104728
Characterization of therapeutic antibodies and related products.Q38058362
The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibodyQ38305605
Ion-exchange chromatography for the characterization of biopharmaceuticalsQ38387706
Characterization of therapeutic antibodies and related products by two-dimensional liquid chromatography coupled with UV absorbance and mass spectrometric detectionQ38856515
Two-Dimensional Liquid Chromatography: A State of the Art TutorialQ39034187
Recent advances in (therapeutic protein) drug development.Q39148639
Assessing analytical methods to monitor isoAsp formation in monoclonal antibodiesQ39252529
Isomerization of a single aspartyl residue of anti-epidermal growth factor receptor immunoglobulin gamma2 antibody highlights the role avidity plays in antibody activityQ40018957
Isoaspartyl post-translational modification triggers anti-tumor T and B lymphocyte immunity.Q40236620
Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodiesQ40374080
Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologicsQ40724867
Direct identification of rituximab main isoforms and subunit analysis by online selective comprehensive two-dimensional liquid chromatography-mass spectrometryQ40767411
Unexpected functional implication of a stable succinimide in the structural stability of Methanocaldococcus jannaschii glutaminase.Q41345453
A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins.Q42280824
Identification of multiple sources of charge heterogeneity in a recombinant antibody.Q43555101
Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity.Q45980125
Succinimide formation at Asn 55 in the complementarity determining region of a recombinant monoclonal antibody IgG1 heavy chain.Q45993219
An improved trypsin digestion method minimizes digestion-induced modifications on proteins.Q46003677
Direct identification and quantification of aspartyl succinimide in an IgG2 mAb by RapiGest assisted digestionQ46161556
A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control StrategyQ46230442
Accumulation of succinimide in a recombinant monoclonal antibody in mildly acidic buffers under elevated temperaturesQ46541519
Intracellular protein modification associated with altered T cell functions in autoimmunityQ48418429
Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies.Q51071625
P433issue1
P304page(s)422-428
P577publication date2019-08-27
P1433published inJournal of Pharmaceutical SciencesQ3186933
P1476titleStructure-Function Assessment and High-Throughput Quantification of Site-Specific Aspartate Isomerization in Monoclonal Antibody Using a Novel Analytical Tool Kit
P478volume109

Search more.